Matrix Healthcare Solutions Granted Direct Access to Pfizer Medicines
Matrix Healthcare Solutions is delighted to announce we have been granted direct access to medicines from Pfizer limited, for the purposes of supplying third party clinical trials, this covers access to the full UK / EU licenced portfolio of 453 lines. The Pfizer portfolio includes a number of oncology, antibacterial, and biologic medicines.
“Establishing our relationship with Pfizer is a great step forward for Matrix as we continue to build on our offering of accessible medicines in the clinical trial supply space. The Pfizer portfolio is extensive, and offers robust, long-term solutions for Sponsors. We look forward to working with Pfizer to support a multitude of studies, for the betterment of human medicines.” – Zac Gilles
Clinical Trial Services from Matrix Healthcare Solutions
“Secure, ethical & global. Raising the bar in clinical supplies.”